Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2012-04-20 | Mr. Bihl is currently Group President AMS, a subsidiary of Endo Pharmaceuticals, with experience in medical device industry operations and finance. |
| 2013-04-18 | Mr. Bihl was Group President American Medical Systems Holdings (AMS), a subsidiary of Endo Pharmaceuticals (Endo), from June 2011 through his retirement in June 2012. Prior to that, he was Chief Executive Officer and a director of AMS from April 2008 until Endo acquired AMS in June 2011. |
| 2014-04-14 | Mr. Bihl has been Chief Executive Officer and a member of the Board of Managers of Bioventus, LLC, a company that develops, manufactures and sells products that promote active orthopaedic healing, since December 2013. From June 2011 through June 2012, he was Group President American Medical Systems (AMS), a subsidiary of Endo Pharmaceuticals (Endo). Prior to that, Mr. Bihl was President & Chief Executive Officer and a director of AMS from April 2008 until Endo acquired AMS in June 2011. He served as Chief Executive Officer of Siemens Medical Solutions’ Diagnostics Division from January to November 2007, and as President of the Diagnostics Division of Bayer HealthCare from 2004 through 2006. Prior to that, Mr. Bihl served in a number of operations and finance roles at Bayer HealthCare and over a 20-year career at E.I. DuPont. |
| 2015-04-13 | Mr. Bihl brings 30 years of experience in the medical device industry, in operations, finance and general management roles. |
Data sourced from SEC filings. Last updated: 2026-02-03